Randomised study: Belotero Intense lip filler achieved a response in 91% of patients
- The Aesthetic Surgery Journal published a multicentre randomised study of Belotero Intense with lidocaine for lip augmentation.
- Belotero Intense achieved a 91.1% responder rate at week 8.
- Belotero Intense was non-inferior to the FDA-approved filler Restylane Silk.
- No severe or serious treatment-related side effects were reported with Belotero Intense over 60 weeks.
Lip augmentation with hyaluronic acid filler is one of the most requested non-surgical treatments. On 14 October 2026 the Aesthetic Surgery Journal published a multicentre, evaluator-blind, randomised study of Belotero Intense with lidocaine.
Study design
Patients with very thin, thin or medium lips, across Fitzpatrick skin types I to VI, were randomised 3:1 to Belotero Intense or the FDA-approved comparator Restylane Silk. A touch-up was allowed at week 4, and safety was followed for up to 60 weeks. A blinded evaluator rated results on the Merz Lip Fullness Assessment Scale (MLFAS), and retreatment at week 48 was offered only to the Belotero group.
Also read: Botulinum toxin type E: phase 3 results show effect within 8 hours and a short duration
Results
- At week 8, 91.1% (144 of 158) responded, beating the pre-set success threshold.
- Belotero Intense met the non-inferiority criterion against Restylane Silk.
- 51.1% of responders kept their improvement through week 48 in a post hoc analysis.
- No severe or serious treatment-related or unexpected adverse events were reported.
Notes
The week-48 durability analysis was post hoc and not a primary goal, so it should be read with caution. Filler results also depend on the injector's skill and technique.
Source: Aesthetic Surgery Journal via PubMed
This story is relayed from the source named above; responsibility for its content rests with the original source.
FAQ
What were the results of the Belotero Intense lip study?
Belotero Intense achieved a 91.1% responder rate at week 8 and was non-inferior to Restylane Silk.
What was Belotero Intense compared with?
Belotero Intense was compared with Restylane Silk with lidocaine, an FDA-approved hyaluronic acid filler.
How long do Belotero Intense lip results last?
In a post hoc analysis, 51.1% of Belotero Intense responders kept their improvement through week 48.
Was Belotero Intense safe in the study?
No severe or serious treatment-related adverse events were reported with Belotero Intense over up to 60 weeks of follow-up.
Did the Belotero Intense study include darker skin types?
Yes. The Belotero Intense study included patients with Fitzpatrick skin types I to VI.


